E-ISSN 2231-3206 | ISSN 2320-4672
 

Case Series

Online Publishing Date:
27 / 12 / 2022

 


A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis

Subhasis Chakraborty, Kana Bal, Debjani Banerjee.


Abstract
Coronavirus diseases 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 virus produce opportunistic fungal infections. Mucormycosis is an acute onset rapidly progressive fatal infection. Incidence of rhino-orbital mucormycosis raised during the second wave of COVID-19 pandemic in India. Diabetes, steroid therapy, cancer, prolonged hospitalization, and metabolic acidosis are the risk factors of post-COVID-19 mucormycosis. Objectives of this study were to suggest the risk factors, clinical features, investigations, and treatment of post-COVID-19 rhino-orbital mucormycosis. This study will guide the future research and the clinician will be aware about this complication of COVID-19. After getting permission from the Institutional Ethical Committee and consent from patients, we studied 10 cases of post-COVID-19 rhino-orbital mucormycosis from April to September 2021 during our duty in COVID-19 admission desk and COVID-19 ward in NRS Medical College, Kolkata. After taking history, we observed the clinical features, investigations, and treatment of the patients. Symptoms of the patients were nasal discharge, nasal block, headache, facial swelling, and blackish discoloration of skin. Most of the patients were diabetic. Magnetic resonance imaging (MRI)-PNS was showed sinonasal mass. Amphotericin-B was used and debridement was the main surgical procedure. Microscopy showed broad aseptate hyphae suggesting mucor. Early diagnosis and proper treatment will reduce the morbidity and mortality of the patient with post-COVID rhino-orbital mucormycosis.

Key words: Coronavirus Diseases 2019; Mucor; Rhino-orbital Mucormycosis


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Subhasis Chakraborty
Articles by Kana Bal
Articles by Debjani Banerjee
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Chakraborty S, Bal K, Banerjee D. A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 438-446. doi:10.5455/njppp.2023.13.11572202216122022


Web Style

Chakraborty S, Bal K, Banerjee D. A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis. https://www.njppp.com/?mno=21778 [Access: March 15, 2024]. doi:10.5455/njppp.2023.13.11572202216122022


AMA (American Medical Association) Style

Chakraborty S, Bal K, Banerjee D. A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 438-446. doi:10.5455/njppp.2023.13.11572202216122022



Vancouver/ICMJE Style

Chakraborty S, Bal K, Banerjee D. A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis. Natl J Physiol Pharm Pharmacol. (2023), [cited March 15, 2024]; 13(2): 438-446. doi:10.5455/njppp.2023.13.11572202216122022



Harvard Style

Chakraborty, S., Bal, . K. & Banerjee, . D. (2023) A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis. Natl J Physiol Pharm Pharmacol, 13 (2), 438-446. doi:10.5455/njppp.2023.13.11572202216122022



Turabian Style

Chakraborty, Subhasis, Kana Bal, and Debjani Banerjee. 2023. A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 438-446. doi:10.5455/njppp.2023.13.11572202216122022



Chicago Style

Chakraborty, Subhasis, Kana Bal, and Debjani Banerjee. "A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 438-446. doi:10.5455/njppp.2023.13.11572202216122022



MLA (The Modern Language Association) Style

Chakraborty, Subhasis, Kana Bal, and Debjani Banerjee. "A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis." National Journal of Physiology, Pharmacy and Pharmacology 13.2 (2023), 438-446. Print. doi:10.5455/njppp.2023.13.11572202216122022



APA (American Psychological Association) Style

Chakraborty, S., Bal, . K. & Banerjee, . D. (2023) A hospital-based study on COVID-19 patients with rhino-orbital mucormycosis. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 438-446. doi:10.5455/njppp.2023.13.11572202216122022